Drugs / pIL15EAM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00775424 | Sep 2008 → Jun 2010 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pIL15EAM | “pIL15EAM is a plasmid that encodes human IL-15 and has been optimized to express 87 fold higher than native IL-15 DNA and 5.7 fold higher than an earlier generation optimized...” NCT00775424 ↗ |
| Modality | Other / unclassified | “pIL15EAM is a plasmid that encodes human IL-15” NCT00775424 ↗ |